A genomic view on epilepsy and autism candidate genes

Genomics

Volumn 108, Issue 1, 2016, Pages 31-36

  Jabbari, Kamel ^a   Nürnberg, Peter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Brain; Chromatin; Isochores; Lamina; Replication timing

Indexed keywords

PROTEOME; ISOCHORE;

ARTICLE; AUTISM; CHROMATIN; EPILEPSY; EXOME; GENE; GENE EXPRESSION; GENE ONTOLOGY; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; ISOCHORE; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; BRAIN; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; METABOLISM; PROCEDURES;

AUTISTIC DISORDER; BRAIN; EPILEPSY; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOMICS; HUMANS; ISOCHORES; PROTEOME;

EID: 84956962235     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2016.01.001     Document Type: Article

References (80)

1. Adachi Y., Käs E., Laemmli U.K. Preferential, cooperative binding of DNA topoisomerase II to scaffold-associated regions. EMBO J. 1989, 8(13):3997-4006.
2. Allen A.S., Berkovic S.F., Cossette P., Delanty N., Dlugos D. Epi4K consortium; epilepsy phenome/genome project. De novo mutations in epileptic encephalopathies. Nature 2013, 501(7466):217-221.
3. Altmüller J., Budde B.S., Nürnberg P. Enrichment of target sequences for next-generation sequencing applications in research and diagnostics. Biol. Chem. 2014, 395(2):231-237.
4. Amit M., Donyo M., Hollander D., Goren A., Kim E., Gelfman S., Lev-Maor G., Burstein D., Schwartz S., Postolsky B., Pupko T., Ast G. Differential GC content between exons and introns establishes distinct strategies of splice-site recognition. Cell Rep. 2012, 5:543-556.
5. Banerjee P.N., Filippi D., Allen H.W. The descriptive epidemiology of epilepsy-a review. Epilepsy Res. 2009, 85(1):31-45.
6. Bayés A., van de Lagemaat L.N., Collins M.O., Croning M.D., Whittle I.R., Choudhary J.S., Grant S.G. Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat. Neurosci. 2011, 14(1):19-21.
7. Bernardi G. The genome: an isochore ensemble and its evolution. Ann. N. Y. Acad. Sci. 2012, 1267:31-34.
8. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., van Emde B.W., Engel J., French J., Glauser T.A., Mathern G.W., Moshé S.L., Nordli D., Plouin P., Scheffer I.E. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005-2009. Epilepsia 2010, 51(4):676-685.
9. Bickmore W.A., van Steensel B. Genome architecture: domain organization of interphase chromosomes. Cell 2013, 152(6):1270-1284.
10. Biervert C., Schroeder B.C., Kubisch C., Berkovic S.F., Propping P., Jentsch T.J., Steinlein O.K. A potassium channel mutation in neonatal human epilepsy. Science 1998, 279(5349):403-406.
11. Campbell I.M., Rao M., Arredondo S.D., Lalani S.R., Xia Z., Kang S.H., Bi W., Breman A.M., Smith J.L., Bacino C.A., Beaudet a., Patel A., Cheung S.W., Lupski J.R., Stankiewicz P., Ramocki M.B., Shaw C.A. Fusion of large-scale genomic knowledge and frequency data computationally prioritizes variants in epilepsy. PLoS Genet. 2013, 9(9).
12. Chandra T., Ewels P.A., Schoenfelder S., Furlan-Magaril M., Wingett S.W., Kirschner K., Thuret J.Y., Andrews S., Fraser P., Reik W. Global reorganization of the nuclear landscape in senescent cells. Cell Rep. 2015, 14:S2211-1247.
13. Charlier C., Singh N.A., Ryan S.G., Lewis T.B., Reus B.E., Leach R.J., Leppert M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet. 1998, 18(1):53-55.
14. Claes L., Del-Favero J., Ceulemans B., Lagae L., Van Broeckhoven C., De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 2001, 68(6):1327-1332.
15. Costantini M., Bernardi G. Replication timing, chromosomal bands, and isochores. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(9):3433-3437.
16. Costantini M., Clay O., Auletta F., Bernardi G. An isochore map of human chromosomes. Genome Res. 2006, 16(4):536-541.
17. Cremer T., Cremer M. Chromosome territories. Cold Spring Harb. Perspect. Biol. 2010, 2(3).
18. Crosetto N., Mitra A., Silva M.J., Bienko M., Dojer N., Wang Q., Karaca E., Chiarle R., Skrzypczak M., Ginalski K., Pasero P., Rowicka M., Dikic I. Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nat. Methods 2013, 10(4):361-365.
19. Cruveiller S., Jabbari K., Clay O., Bernardi G. Compositional gene landscapes in vertebrates. Genome Res. 2004, 14(5):886-892.
20. De Rubeis S., He X., Goldberg A.P., Poultney C.S., Samocha K., Cicek A.E., et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014, 515(7526):209-215.
21. Duret L., Mouchiroud D., Gautier C. Statistical analysis of vertebrate sequences reveals that long genes are scarce in GC-rich isochores. J. Mol. Evol. 1995, 40(3):308-317.
22. EpiPM Consortium A roadmap for precision medicine in the epilepsies. Lancet Neurol. 2015, 14(12):1219-1228.
23. Flicek P., Amode M.R., Barrell D., Beal K., Billis K., et al. Ensembl 2014. Nucleic Acids Res. 2014, 42(Database issue):D749-D755.
24. Gabel H.W., Kinde B., Stroud H., Gilbert C.S., Harmin D.A., Kastan N.R., Hemberg M., Ebert D.H., Greenberg M.E. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Nature 2015.
25. Gilby K.L., O'Brien T.J. Epilepsy, autism, and neurodevelopment: kindling a shared vulnerability?. Epilepsy Behav. 2013, 26(3):370-374.
26. Girirajan S., Campbell C.D., Eichler E.E. Human copy number variation and complex genetic disease. Annu. Rev. Genet. 2011, 45:203-226.
27. Hegde M., Lowenstein D.H. The search for circulating epilepsy biomarkers. Biomark. Med 2014, 8(3):413-427.
28. Hiratani I., Leskovar A., Gilbert D.M. Differentiation-induced replication-timing changes are restricted to AT-rich/long interspersed nuclear element (LINE)-rich isochores. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(48):16861-16866.
29. Hiratani I., Takebayashi S., Lu J., Gilbert D.M. Replication timing and transcriptional control: beyond cause and effect-part II. Curr. Opin. Genet. Dev. 2009, 19(2):142-149.
30. Hormozdiari F., Penn O., Borenstein E., Eichler E.E. The discovery of integrated gene networks for autism and related disorders. Genome Res. 2015, 25(1):142-154.
31. Ibn-Salem J., Köhler S., Love M.I., Chung H.R., Huang N., Hurles M.E., Haendel M., Washington N.L., Smedley D., Mungall C.J., Lewis S.E., Ott C.E., Bauer S., Schofield P.N., Mundlos S., Spielmann M., Robinson P.N. Deletions of chromosomal regulatory boundaries are associated with congenital disease. Genome Biol. 2014, 4;15(9):423.
32. Jabbari K., Bernardi G. CpG doublets, CpG islands and Alu repeats in long human DNA sequences from different isochore families. Gene 1998, 224(1-2):123-127.
33. Kodera H., Kato M., Nord A.S., Walsh T., Lee M., Yamanaka G., Tohyama J., Nakamura K., Nakagawa E., Ikeda T., Ben-Zeev B., Lev D., Lerman-Sagie T., Straussberg R., Tanabe S., Ueda K., Amamoto M., Ohta S., Nonoda Y., Nishiyama K., Tsurusaki Y., Nakashima M., Miyake N., Hayasaka K., King M.C., Matsumoto N., Saitsu H. Targeted capture and sequencing for detection of mutations causing early onset epileptic encephalopathy. Epilepsia 2013, 54(7):1262-1269.
34. Kidd S.A., Lachiewicz A., Barbouth D., Blitz R.K., Delahunty C., McBrien D., Visootsak J., Berry-Kravis E. Fragile X syndrome: a review of associated medical problems. Pediatrics 2014, 134(5):995-1005.
35. King I.F., Yandava C.N., Mabb A.M., Hsiao J.S., Huang H.S., Pearson B.L., Calabrese J.M., Starmer J., Parker J.S., Magnuson T., Chamberlain S.J., Philpot B.D., Zylka M.J. Topoisomerases facilitate transcription of long genes linked to autism. Nature 2013, 501(7465):58-62.
36. Landrum M.J., Lee J.M., Riley G.R., Jang W., Rubinstein W.S., Church D.M., Maglott D.R. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014, 42(Database issue):D980-D985.
37. Le Tallec B., Millot G.A., Blin M.E., Brison O., Dutrillaux B., Debatisse M. Common fragile site profiling in epithelial and erythroid cells reveals that most recurrent cancer deletions lie in fragile sites hosting large genes. Cell Rep. 2013, 4(3):420-428. (15).
38. Lemke J.R., Riesch E., Scheurenbrand T., Schubach M., Wilhelm C., Steiner I., Hansen J., Courage C., Gallati S., Bürki S., Strozzi S., Simonetti B.G., Grunt S., Steinlin M., Alber M., Wolff M., Klopstock T., Prott E.C., Lorenz R., Spaich C., Rona S., Lakshminarasimhan M., Kröll J., Dorn T., Krämer G., Synofzik M., Becker F., Weber Y.G., Lerche H., Böhm D., Biskup S. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia 2012, 53(8):1387-1398.
39. Lev Maor G., Yearim A., Ast G. The alternative role of DNA methylation in splicing regulation. Trends Genet. 2015, 31(5):274-280.
40. Lu J., Li H., Hu M., Sasaki T., Baccei A., Gilbert D.M., Liu J.S., Collins J.J., Lerou P.H. The distribution of genomic variations in human iPSCs is related to replication-timing reorganization during reprogramming. Cell Rep. 2014, 7(1):70-78. (10).
41. Lupiáñez D.G., Kraft K., Heinrich V., Krawitz P., Brancati F., Klopocki E., Horn D., Kayserili H., Opitz J.M., Laxova R., Santos-Simarro F., Gilbert-Dussardier B., Wittler L., Borschiwer M., Haas S.A., Osterwalder M., Franke M., Timmermann B., Hecht J., Spielmann M., Visel A., Mundlos S. Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions. Cell 2015, 161(5):1012-1025. (21).
42. Malhotra D., Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell Mar 16, 2012, 148(6):1223-1241.
43. Meuleman W., Peric-Hupkes D., Kind J., Beaudry J.B., Pagie L., Kellis M., Reinders M., Wessels L., van Steensel B. Constitutive nuclear lamina-genome interactions are highly conserved and associated with a/T-rich sequence. Genome Res. 2013, 23(2):270-280.
44. Miura P., Shenker S., Andreu-Agullo C., Westholm J.O., Lai E.C. Widespread and extensive lengthening of 3' UTRs in the mammalian brain. Genome Res. 2013, 23(5):812-825.
45. Muhle R., Trentacoste S.V., Rapin I. The genetics of autism. Pediatrics 2004, 113(5):e472-e486.
46. Noebels J. Pathway-driven discovery of epilepsy genes. Nat. Neurosci. 2015, 18(3):344-350.
47. Neligan A., Hauser W.A., Sander J.W. The epidemiology of the epilepsies. Handb. Clin. Neurol. 2012, 107:113-133.
48. Newton C.R., Kariuki S.M. Status epilepticus in sub-Saharan Africa: new findings. Epilepsia 2013, 54(Suppl. 6):50-53.
49. Niimura Y., Gojobori T. In silico chromosome staining: reconstruction of Giemsa bands from the whole human genome sequence. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(2):797-802. (22).
50. Papetti L., Parisi P., Leuzzi V., Nardecchia F., Nicita F., Ursitti F., Marra F., Paolino M.C., Spalice A. Metabolic epilepsy: an update. Brain Dev. 2013, 35(9):827-841.
51. Pesole G., Bernardi G., Saccone C. Isochore specificity of AUG initiator context of human genes. FEBS Lett. 1999, 464(1-2):60-62. (24).
52. Poduri A., Lowenstein D. Epilepsy genetics-past, present, and future. Curr. Opin. Genet. Dev. 2011, 21(3):325-332.
53. Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., Kordasiewicz H., Sedaghat Y., Donohue J.P., Shiue L., Bennett C.F., Yeo G.W., Cleveland D.W. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011, 14(4):459-468.
54. Powell W.T., Coulson R.L., Gonzales M.L., Crary F.K., Wong S.S., Adams S., Ach R.A., Tsang P., Yamada N.A., Yasui D.H., Chédin F., LaSalle J.M. R-loop formation at Snord116mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(34):13938-13943.
55. Power R.A., Kyaga S., Uher R., MacCabe J.H., Långström N., Landen M., McGuffin P., Lewis C.M., Lichtenstein P., Svensson A.C. Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. JAMA Psychiatry 2013, 70(1):22-30.
56. Ran X., Li J., Shao Q., Chen H., Lin Z., Sun Z.S., Wu J. EpilepsyGene: a genetic resource for genes and mutations related to epilepsy. Nucleic Acids Res. 2015, 43(Database issue):D893-D899. (28).
57. Ren L., Gao G., Zhao D., Ding M., Luo J., Deng H. Developmental stage related patterns of codon usage and genomic GC content: searching for evolutionary fingerprints with models of stem cell differentiation. Genome Biol. 2007, 8(3):R35.
58. Sano K., Miyaji-Yamaguchi M., Tsutsui K.M., Tsutsui K. Topoisomerase IIbeta activates a subset of neuronal genes that are repressed in AT-rich genomic environment. PLoS ONE 2008, 3(12).
59. Saxonov S., Berg P., Brutlag D.L. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. PNAS 2006, 103(5):1412-1417. (31).
60. Shohat S., Shifman S. Bias towards large genes in autism. Nature 2014, 512(7512):E1-E2. (7).
61. Singh N.A., Charlier C., Stauffer D., Du Pont B.R., Leach R.J., Melis R., Ronen G.M., Bjerre I., Quattlebaum T., Murphy J.V., McHarg M.L., Gagnon D., Rosales T.O., Peiffer A., Anderson V.E., Leppert M. A novel potassium channel gene, KCNQ2, is mutated in aninherited epilepsy of newborns. Nat. Genet. 1998, 18(1):25-29.
62. Skre H. A study of certain traits accompanying some inherited neurological disorders. Clin. Genet. 1975, 8(2):117-135.
63. Smibert P., Miura P., Westholm J.O., Shenker S., May G., Duff M.O., Zhang D., Eads B.D., Carlson J., Brown J.B., Eisman R.C., Andrews J., Kaufman T., Cherbas P., Celniker S.E., Graveley B.R., Lai E.C. Global patterns of tissue-specific alternative polyadenylation in Drosophila. Cell Rep. 2012, 1(3):277-289. (Erratum in: Cell Rep. 2013; 28; 3(3), 29).
64. Smith D.I., Zhu Y., McAvoy S., Kuhn R. Common fragile sites, extremely large genes, neural development and Cancer. Cancer Lett. 2006, 232(1):48-57. (28).
65. Staley K. Molecular mechanisms of epilepsy. Nat. Neurosci. 2015, 18(3):367-372.
66. Stefansson H., Rujescu D., Cichon S., Pietiläinen O.P., Ingason A. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455(7210):232-236.
67. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., Scheffer I.E., Berkovic S.F. A missense mutation in the neuronal nicotinicacetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 1995, 11(2):201-203.
68. Strømme P., Mangelsdorf M.E., Scheffer I.E., Gécz J. Infantile spasms, dystonia,and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, ARX. Brain Dev. 2002, 24(5):266-268.
69. Thakurela S., Garding A., Jung J., Schübeler D., Burger L., Tiwari V.K. Gene regulation and priming by topoisomerase IIα in embryonic stem cells. Nat. Commun. 2013, 4:2478.
70. Thurman D.J., Beghi E., Begley C.E., Berg A.T., Buchhalter J.R., Ding D., Hesdorffer D.C., Hauser W.A., Kazis L., Kobau R., Kroner B., Labiner D., Liow K., Logroscino G., MedinaMT N.C.R., Parko K., Paschal A., Preux P.M., Sander J.W., Selassie A., Theodore W., Tomson T., Wiebe S. ILAE Commission on Epidemiology. Standards for epidemiologicstudies and surveillance of epilepsy. Epilepsia 2011, 52(Suppl. 7):2-26.
71. Tuchman R., Rapin I. Epilepsy in autism. Lancet Neurol. 2002, 1(6):352-358.
72. Uddin M., Tammimies K., Pellecchia G., Alipanahi B., Hu P., Wang Z., Pinto D., Lau L., Nalpathamkalam T., Marshall C.R., Blencowe B.J., Frey B.J., Merico D., Yuen R.K., Scherer S.W. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat. Genet. 2014, 46(7):742-747.
73. Wallace R.H., Wang D.W., Singh R., Scheffer I.E., George A.L., Phillips H.A., Saar K., Reis A., Johnson E.W., Sutherland G.R., Berkovic S.F., Mulley J.C. Febrile seizures and generalized epilepsy associated with a mutation in the Na + -channel beta1 subunit gene SCN1B. Nat. Genet. 1998, 19(4):366-370.
74. Wilson T.E., Arlt M.F., Park S.H., Rajendran S., Paulsen M., Ljungman M., Glover T.W. Large transcription units unify copy number variants and common fragile sites arising under replication stress. Genome Res. 2015, 25(2):189-200.
75. Woolfenden S., Sarkozy V., Ridley G., Coory M., Williams K. A systematic review of two outcomes in autism spectrum disorder - epilepsy and mortality. Dev. Med. Child Neurol. 2012, 54(4):306-312.
76. Yang J., Gu Z., Li W.H. Rate of protein evolution versus fitness effect of gene deletion. Mol. Biol. Evol. 2003, 20(5):772-774.
77. Zylka M.J., Simon J.M., Philpot B.D. Gene length matters in neurons. Neuron 2015, 86(2):353-355.
78. Thomas R.H., Berkovic S.F. The hidden genetics of epilepsy-a clinically important new paradigm. Nat. Rev. Neurol. 2014, 10(5):283-292.
79. Harkin L.A., McMahon J.M., Iona X., Dibbens L., Pelekanos J.T., Zuberi S.M., Sadleir L.G., Andermann E., Gill D., Farrell K., Connolly M., Stanley T., Harbord M., Andermann F., Wang J., Batish S.D., Jones J.G., Seltzer W.K., Gardner A. Infantile Epileptic Encephalopathy Referral Consortium. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 2007, 130:843-852.
80. Iossifov I., O'Roak B.J., Sanders S.J., Ronemus M., Krumm N., Levy D., Stessman H.A., Witherspoon K.T., Vives L., Patterson K.E., Smith J.D., Paeper B., Nickerson D.A., Dea J., Dong S., Gonzalez L.E., Mandell J.D., Mane S.M., Murtha M.T., Sullivan C.A., Walker M.F., Waqar Z., Wei L., Willsey A.J., Yamrom B., Lee Y.H., Grabowska E., Dalkic E., Wang Z., Marks S., Andrews P., Leotta A., Kendall J., Hakker I., Rosenbaum J., Ma B., Rodgers L., Troge J., Narzisi G., Yoon S., Schatz M.C., Ye K., McCombie W.R., Shendure J., Eichler E.E., State M.W., Wigler M. The contribution of de novo coding mutations to autism spectrum disorder. Nature 2014 Nov 13, 515(7526):216-221.